- Home
- BDRX vs HSDT Comparison
BDRX vs HSDT Comparison
Compare BDRX & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- HSDT
- Stock Information
- Founded
- BDRX 2000
- HSDT 2014
- Country
- BDRX United Kingdom
- HSDT United States
- Employees
- BDRX N/A
- HSDT N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BDRX Health Care
- HSDT Health Care
- Exchange
- BDRX Nasdaq
- HSDT Nasdaq
- Market Cap
- BDRX 2.4M
- HSDT 2.9M
- IPO Year
- BDRX N/A
- HSDT N/A
- Fundamental
- Price
- BDRX $3.71
- HSDT $0.54
- Analyst Decision
- BDRX
- HSDT Buy
- Analyst Count
- BDRX 0
- HSDT 2
- Target Price
- BDRX N/A
- HSDT $24.00
- AVG Volume (30 Days)
- BDRX 1.2M
- HSDT 241.1K
- Earning Date
- BDRX 04-21-2025
- HSDT 03-27-2025
- Dividend Yield
- BDRX N/A
- HSDT N/A
- EPS Growth
- BDRX N/A
- HSDT N/A
- EPS
- BDRX N/A
- HSDT N/A
- Revenue
- BDRX $104,895.00
- HSDT $502,000.00
- Revenue This Year
- BDRX N/A
- HSDT N/A
- Revenue Next Year
- BDRX N/A
- HSDT $8.97
- P/E Ratio
- BDRX N/A
- HSDT N/A
- Revenue Growth
- BDRX N/A
- HSDT N/A
- 52 Week Low
- BDRX $3.36
- HSDT $0.37
- 52 Week High
- BDRX $74.00
- HSDT $7.19
- Technical
- Relative Strength Index (RSI)
- BDRX 38.74
- HSDT 43.07
- Support Level
- BDRX $3.36
- HSDT $0.50
- Resistance Level
- BDRX $5.30
- HSDT $0.60
- Average True Range (ATR)
- BDRX 0.74
- HSDT 0.06
- MACD
- BDRX -0.08
- HSDT -0.01
- Stochastic Oscillator
- BDRX 5.99
- HSDT 15.87
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.